{"id":"elontril","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Alcohol withdrawal-induced convulsion","Alcoholism","Anorexia nervosa","Bipolar affective disorder, current episode manic","Bulimia nervosa","Cirrhosis of liver","Diabetic - poor control","Disease of liver","Feeling agitated","Hepatic failure","Hostile behavior","Hypertensive disorder","Injury of head","Kidney disease","Lowered convulsive threshold","Mood swings","Myocardial infarction","Neoplasm of central nervous system","Opioid dependence","Panic disorder","Psychotic disorder","Secondary malignant neoplasm of cerebrum","Sedative Drug Dependence","Seizure disorder","Seizure due to Abrupt Benzodiazepine Withdrawal","Stimulant Drug Dependence","Suicidal thoughts","Weight loss"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":["Bupropion hydrochloride"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Cytochrome P450 2C19, Neuronal acetylcholine receptor subunit alpha-7, Alpha-1A adrenergic receptor"},"_scrapedAt":"2026-03-28T00:46:11.571Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Depressive disorder","diseaseId":"depressive-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Major depressive disorder","diseaseId":"major-depressive-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nicotine dependence","diseaseId":"nicotine-dependence","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Obesity","diseaseId":"obesity","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Seasonal affective disorder","diseaseId":"seasonal-affective-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Smoking cessation assistance","diseaseId":"smoking-cessation-assistance","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04899674","phase":"PHASE1","title":"A Study in Healthy Men and Women to Test Whether BI 1358894 Influences the Amount of Bupropion in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2021-06-30","conditions":"Healthy","enrollment":18},{"nctId":"NCT05160090","phase":"PHASE1","title":"Single Dose Crossover Comparative Bioavailability Study of Bupropion Hcl MR Tablet 300mg","status":"COMPLETED","sponsor":"Alembic Pharmaceuticals Ltd.","startDate":"2020-01-18","conditions":"Bioequivalence","enrollment":34},{"nctId":"NCT04757532","phase":"PHASE1","title":"Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers.","status":"COMPLETED","sponsor":"Parc de Salut Mar","startDate":"2020-12-03","conditions":"Healthy Volunteers","enrollment":9},{"nctId":"NCT01047254","phase":"PHASE3","title":"Bupropion for the Treatment of Apathy in Alzheimer's Dementia","status":"COMPLETED","sponsor":"University Hospital, Bonn","startDate":"2010-01","conditions":"Apathy in Dementia","enrollment":110},{"nctId":"NCT01914965","phase":"PHASE2","title":"Apathy Cure Through Bupropion in Huntington's Disease","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2012-06","conditions":"Apathy, Huntington's Disease","enrollment":40}],"_emaApprovals":[],"_faersSignals":[{"count":67,"reaction":"DRUG INTERACTION"},{"count":54,"reaction":"NAUSEA"},{"count":45,"reaction":"SUICIDE ATTEMPT"},{"count":33,"reaction":"INTENTIONAL OVERDOSE"},{"count":30,"reaction":"DIZZINESS"},{"count":29,"reaction":"TREMOR"},{"count":28,"reaction":"CONFUSIONAL STATE"},{"count":28,"reaction":"CONVULSION"},{"count":28,"reaction":"FOETAL EXPOSURE DURING PREGNANCY"},{"count":28,"reaction":"RESTLESSNESS"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":4,"therapeuticAreas":["Metabolic"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_3","status":"active","brandName":"Elontril","genericName":"Elontril","companyName":"Boehringer Ingelheim","companyId":"boehringer-ingelheim","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}